PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 219 filers reported holding PACIRA PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 0.77 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $12,020,000 | +9.0% | 276,378 | -4.6% | 1.18% | +11.1% |
| Q1 2019 | $11,030,000 | -10.4% | 289,812 | +29.0% | 1.07% | -12.5% |
| Q4 2018 | $12,308,000 | -25.0% | 224,739 | -15.3% | 1.22% | -2.2% |
| Q3 2018 | $16,416,000 | +48.7% | 265,255 | -22.3% | 1.25% | +51.5% |
| Q2 2018 | $11,041,000 | -10.4% | 341,580 | -13.0% | 0.82% | -15.1% |
| Q1 2018 | $12,328,000 | -19.9% | 392,515 | +17.4% | 0.97% | -9.8% |
| Q4 2017 | $15,385,000 | +48.0% | 334,297 | +21.6% | 1.07% | +41.3% |
| Q3 2017 | $10,398,000 | -10.2% | 274,842 | +13.4% | 0.76% | -11.7% |
| Q2 2017 | $11,575,000 | +3461.5% | 242,293 | +3528.2% | 0.86% | +3813.6% |
| Q1 2017 | $325,000 | – | 6,678 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Advisers, LP | 360,000 | $21,845,000 | 6.19% |
| Gagnon Advisors, LLC | 213,217 | $12,938,000 | 4.92% |
| GAGNON SECURITIES LLC | 499,333 | $30,300,000 | 4.30% |
| Spyglass Capital Management LLC | 2,117,673 | $128,500,000 | 2.86% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 646,530 | $39,231,000 | 2.30% |
| Paulson & Co. | 1,273,161 | $77,255,000 | 1.85% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 212,112 | $12,871,000 | 1.44% |
| Tygh Capital Management, Inc. | 152,332 | $9,244,000 | 1.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,147,000 | $69,600,000 | 1.24% |
| Rock Springs Capital Management LP | 1,025,000 | $62,197,000 | 1.23% |